In order to investigate whether YKL-40 is associated with secretion of other inflammatory markers, we also quantified CSF levels of the glial fibrillary acidic protein (GFAP), a marker for astrocyte activation, and a panel of pro-inflammatory chemokines in AD patients and non-demented controls. Here, GFAP is linked to Alzheimer disease.